APAC IUCD devices Market

September 2017 | 150 pages | ID: A5A37A38676EN
Data Bridge Market Research

Abstracts

In this region, The APAC IUCD devices market is projected to reach USD 2,533.9 million by 2024, from USD 2,161.5 million in 2016 growing at a CAGR of 2.0% in the forecast period 2017 to 2024.

Based on geography, the APAC IUCD devices market is segmented into 11 geographical regions, such as,

• Japan,
• China,
• South Korea,
• India,
• Australia,
• Singapore,
• Thailand,
• Malaysia,
• Indonesia,
• Philippines and
• Rest Of APAC.

APAC IUCD devices market competition by top players including –

Bayer AG dominated the IUCD devices market, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Also Medigen Distribution, Inc. and Allergen PLC are expected to hold respectively. Some of the other players in this market include

• DKT International,
• Egemen International,
• Melbea AG,
• Ocon Medical Ltd.,
• Pregna International Limited,
• Medical Engineering Corporation SA
• SMB Corporation
• Meril Life Sciences Pvt. Ltd.,
• Medu Scientific Ltd,
• China RH Contraceptives Co., Ltd,
• Sanghai Jolly Medical Education Co., Ltd,
• Bernstein Leibhard LLP,
• Zheijang Daji Medical Instruments, Ltd.,
• Nimble International,
• AME Line,
• Technico,
• Cepeo,
• Contraceptivos,
• Injeflex Ind And Com Ltda,
• Bersil, Amed

The APAC intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The APAC intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare.

Contents

1. INTRODUCTION

1.1. OVERVIEW OF ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE
DEVICES (IUCD) MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES
  3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
  3.1.3. FAVOURABLE INSURANCE FOR IUCD’S
  3.1.4. GROWING AWARENESS OF CONTRACEPTIVE
  3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
  3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
  3.2.1. HIGH COST OF TREATMENT
  3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
  3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
  3.2.4. CHANGES IN GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

7. ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. APAC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.1. CHINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.2. SOUTH KOREA INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.3. JAPAN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.4. INDIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.5. THAILAND INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.6. SINGAPORE INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.7. MALAYSIA INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.8. PHILIPPINES INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.9. AUSTRALIA INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.10. INDONESIA INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET

8. ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

8.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

9. COMPANY PROFILES

9.1. BAYER AG
  9.1.1. COMPANY OVERVIEW
  9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.1.3. REVENUE ANALYSIS
  9.1.4. PRODUCT PORTFOLIO
  9.1.5. RECENT DEVELOPMENTS
  9.1.6. DATA BRIDGE ANALYSIS
9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  9.2.1. COMPANY OVERVIEW
  9.2.2. REVENUE ANALYSIS
  9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.2.4. PRODUCT PORTFOLIO
  9.2.5. RECENT DEVELOPMENTS
  9.2.6. DATA BRIDGE ANALYSIS
9.3. ALLERGEN PLC
  9.3.1. COMPANY OVERVIEW
  9.3.2. REVENUE ANALYSIS
  9.3.3. PRODUCT PORTFOLIO
  9.3.4. RECENT DEVELOPMENTS
  9.3.5. DATA BRIDGE ANALYSIS
9.4. DKT INTERNATIONAL
  9.4.1. COMPANY OVERVIEW
  9.4.2. REVENUE ANALYSIS
  9.4.3. PRODUCT PORTFOLIO
9.5. SMB CORPORATION
  9.5.1. COMPANY OVERVIEW
  9.5.2. REVENUE ANALYSIS
  9.5.3. PRODUCT PORTFOLIO
  9.5.4. RECENT DEVELOPMENTS
  9.5.5. DATA BRIDGE ANALYSIS
9.6. OCON MEDICAL LTD.
  9.6.1. COMPANY OVERVIEW
  9.6.2. REVENUE ANALYSIS
  9.6.3. PRODUCT PORTFOLIO
  9.6.4. RECENT DEVELOPMENTS
  9.6.5. DATA BRIDGE ANALYSIS
9.7. MONA LISA N.V.
  9.7.1. COMPANY OVERVIEW
  9.7.2. REVENUE ANALYSIS
  9.7.3. PRODUCT PORTFOLIO
  9.7.4. RECENT DEVELOPMENTS
9.8. MEDISAFE DISTRIBUTION INC.
  9.8.1. COMPANY OVERVIEW
  9.8.2. REVENUE ANALYSIS
  9.8.3. PRODUCT PORTFOLIO
  9.8.4. RECENT DEVELOPMENTS

10. RELATED REPORTS

TABLE LIST

TABLE 1 APAC IUCD DEVICES MARKET, BY COUNTRY, 2013 – 2024 (USD MILLION)
TABLE 2 APAC IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 3 APAC IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 4 APAC IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 5 JAPAN IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 6 JAPAN IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 7 JAPAN IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 8 INDIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 9 INDIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 10 INDIA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 11 THAILAND IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 12 THAILAND IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 13 THAILAND IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 14 SINGAPORE IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 15 SINGAPORE IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 16 SINGAPORE IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 17 MALAYSIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 18 MALAYSIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 19 MALAYSIA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 20 PHILIPPINES IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 21 PHILIPPINES IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 22 PHILIPPINES IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 23 AUSTRALIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 24 AUSTRALIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 25 AUSTRALIA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 26 INDONESIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 27 INDONESIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 28 INDONESIA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)

Figures

FIGURES LIST

FIGURE 1 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: GEOGRAHIC SCOPE
FIGURE 3 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 4 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: SNAPSHOT
FIGURE 5 ASIA PACIFIC IUCD DEVICES MARKET: BOTTOM UP APPROACH
FIGURE 6 ASIA PACIFIC IUCD DEVICES MARKET: TOP DOWN APPROACH
FIGURE 7 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 ASIA PACIFIC IUCD DEVICES MARKET: BY PRODUCT TYPE, SNAPSHOT 2024
FIGURE 9 ASIA PACIFIC IUCD DEVICES MARKET: BY GEOGRAPHY, 2016
FIGURE 10 APAC IUCD DEVICES MARKET: BY COUNTRY, SNAPSHOT 2016 & 2024
FIGURE 11 ASIA PACIFIC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET:
COMPANY SHARE 2016 (%)
FIGURE 12 ASIA PACIFIC IUCD DEVICES MARKET: COMPANY SHARE 2016 (%)

COMPNIES PROFILES

DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA SMB Corporation Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP